An open-label pilot trial of a five-day, accelerated rTMS protocol in bipolar II depression
- PMID: 39341287
- DOI: 10.1016/j.jad.2024.09.159
An open-label pilot trial of a five-day, accelerated rTMS protocol in bipolar II depression
Conflict of interest statement
Declaration of competing interest Giovanni Martinotti has served as a consultant, speaker, and recipient of research grants from companies including Angelini, Doc Generici, Janssen-Cilag, Lundbeck, Otsuka, Pfizer, Servier, and Recordati. Giorgio Di Lorenzo has held roles as a speaker and consultant for Angelini, FB-Health, Janssen-Cilag, Livanova, Lundbeck, Neuraxpharm, Otsuka, and Recordati. The other authors report no commercial or financial relationships that could be construed as a potential conflict of interest regarding this research.
Publication types
LinkOut - more resources
Full Text Sources